Suppr超能文献

临床前阿尔茨海默病中综合评分对淀粉样蛋白负荷的敏感性:引入非痴呆老年人注意力、语言流畅性和情景记忆的Z评分综合评分。

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score.

作者信息

Lim Yen Ying, Snyder Peter J, Pietrzak Robert H, Ukiqi Albulene, Villemagne Victor L, Ames David, Salvado Olivier, Bourgeat Pierrick, Martins Ralph N, Masters Colin L, Rowe Christopher C, Maruff Paul

机构信息

The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.

Department of Neurology, Warren Alpert School of Medicine, Brown University, Providence, RI, USA; Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, RI, USA.

出版信息

Alzheimers Dement (Amst). 2015 Dec 12;2:19-26. doi: 10.1016/j.dadm.2015.11.003. eCollection 2016.

Abstract

INTRODUCTION

Cognitive composite scores developed for preclinical Alzheimer's disease (AD) often consist of multiple cognitive domains as they may provide greater sensitivity to detect β-amyloid (Aβ)-related cognitive decline than episodic memory (EM) composite scores alone. However, this has never been empirically tested. We compared the rate of cognitive decline associated with high Aβ (Aβ+) and very high Aβ (Aβ++) in cognitively normal (CN) older adults on three multidomain cognitive composite scores and one single-domain (EM) composite score.

METHODS

CN older adults (n = 423) underwent Aβ neuroimaging and completed neuropsychological assessments at baseline, and at 18-, 36-, 54-, and 72-month follow-ups. Four cognitive composite scores were computed: the ADCS-PACC (ADCS-Preclinical Alzheimer Cognitive Composite), ADCS-PACC without the inclusion of the mini-mental state examination (MMSE), an EM composite, and the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults (ZAVEN) composite.

RESULTS

Compared with Aβ+ CN older adults, Aβ++ CN older adults showed faster rates of decline across all cognitive composites, with the largest decline observed for ZAVEN composite (d = 1.07). Similarly, compared with Aβ- CN older adults, Aβ+ CN older adults also showed faster rates of cognitive decline, but only for the ADCS-PACC no MMSE (d = 0.43), EM (d = 0.53), and ZAVEN (d = 0.50) composites.

DISCUSSION

Aβ-related cognitive decline is best detected using validated neuropsychological instruments. Removal of the MMSE from the ADCS-PACC and replacing it with a test of executive function (verbal fluency; i.e., the ZAVEN) rendered this composite more sensitive even in detecting Aβ-related cognitive decline between Aβ+ and Aβ++ CN older adults.

摘要

引言

为临床前阿尔茨海默病(AD)开发的认知综合评分通常由多个认知领域组成,因为与仅使用情景记忆(EM)综合评分相比,它们可能对检测β-淀粉样蛋白(Aβ)相关的认知衰退具有更高的敏感性。然而,这从未得到实证检验。我们比较了认知正常(CN)的老年人中,高Aβ(Aβ+)和非常高Aβ(Aβ++)状态下,在三个多领域认知综合评分和一个单领域(EM)综合评分上的认知衰退率。

方法

CN老年人(n = 423)接受了Aβ神经影像学检查,并在基线以及18个月、36个月、54个月和72个月随访时完成了神经心理学评估。计算了四个认知综合评分:ADCS-PACC(ADCS临床前阿尔茨海默病认知综合评分)、不包括简易精神状态检查(MMSE)的ADCS-PACC、一个EM综合评分,以及非痴呆老年人的注意力、语言流畅性和情景记忆的Z评分(ZAVEN)综合评分。

结果

与Aβ+的CN老年人相比,Aβ++的CN老年人在所有认知综合评分上均显示出更快的衰退率,其中ZAVEN综合评分下降幅度最大(d = 1.07)。同样,与Aβ-的CN老年人相比,Aβ+的CN老年人也显示出更快的认知衰退率,但仅在不包括MMSE的ADCS-PACC(d = 0.43)、EM(d = 0.53)和ZAVEN(d = 0.50)综合评分上。

讨论

使用经过验证的神经心理学工具能最好地检测出Aβ相关的认知衰退。从ADCS-PACC中去除MMSE并用执行功能测试(语言流畅性;即ZAVEN)取而代之,使得该综合评分在检测Aβ+和Aβ++的CN老年人之间的Aβ相关认知衰退时更加敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2431/4879646/c7342ccd0e33/gr1.jpg

相似文献

2
Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
J Clin Exp Neuropsychol. 2019 Aug;41(6):591-600. doi: 10.1080/13803395.2019.1593949. Epub 2019 Mar 29.
4
The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
JAMA Neurol. 2014 Aug;71(8):961-70. doi: 10.1001/jamaneurol.2014.803.
6
Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5.
Alzheimers Dement (N Y). 2017 Nov 10;3(4):668-677. doi: 10.1016/j.trci.2017.10.004. eCollection 2017 Nov.
10
Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β.
Alzheimers Dement. 2017 Sep;13(9):1004-1012. doi: 10.1016/j.jalz.2017.01.018. Epub 2017 Feb 28.

引用本文的文献

3
Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease.
J Prev Alzheimers Dis. 2024;11(6):1696-1702. doi: 10.14283/jpad.2024.130.
5
Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer's disease.
Alzheimers Dement. 2024 Oct;20(10):6935-6947. doi: 10.1002/alz.14163. Epub 2024 Sep 6.
6
CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease.
Alzheimers Dement. 2024 Sep;20(9):5819-5832. doi: 10.1002/alz.13862. Epub 2024 Jul 19.
8
Pick a PACC: Comparing domain-specific and general cognitive composites in Alzheimer disease research.
Neuropsychology. 2024 Jul;38(5):443-464. doi: 10.1037/neu0000949. Epub 2024 Apr 11.
9
Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer's Disease.
bioRxiv. 2024 Mar 11:2024.03.07.584012. doi: 10.1101/2024.03.07.584012.
10

本文引用的文献

1
Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.
Ann Clin Transl Neurol. 2015 May;2(5):534-47. doi: 10.1002/acn3.192. Epub 2015 Mar 21.
2
APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.
Mol Psychiatry. 2015 Nov;20(11):1322-8. doi: 10.1038/mp.2014.123. Epub 2014 Oct 7.
3
Standardized mini-mental state examination scores and verbal memory performance at a memory center: implications for cognitive screening.
Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):145-52. doi: 10.1177/1533317514539378. Epub 2014 Jul 1.
4
The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
JAMA Neurol. 2014 Aug;71(8):961-70. doi: 10.1001/jamaneurol.2014.803.
5
Secondary prevention trials in Alzheimer disease: the challenge of identifying a meaningful end point.
JAMA Neurol. 2014 Aug;71(8):947-9. doi: 10.1001/jamaneurol.2014.1120.
7
Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.
Neurology. 2014 May 20;82(20):1760-7. doi: 10.1212/WNL.0000000000000431. Epub 2014 Apr 18.
8
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.
Mol Psychiatry. 2014 Sep;19(9):1044-51. doi: 10.1038/mp.2014.9. Epub 2014 Mar 11.
10
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Brain. 2014 Jan;137(Pt 1):221-31. doi: 10.1093/brain/awt286. Epub 2013 Oct 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验